Universitätsklinikum Tübingen

MOR202 with Low-Dose Dexamethasone (Dex) or Pomalidomide/Dex or Lenalidomide/Dex in Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis of a Phase I/IIa, Multicenter, Dose-Escalation Study (2018) Raab MS, Chatterjee M, Goldschmidt H, Agis H, Blau I, Einsele H, Engelhardt M, et al. Conference contribution Invariant Natural Killer T Cells from Donor Lymphocyte Infusions (DLI-iNKTs) Contribute to Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplantation (2018) Jahnke S, Schmid H, Secker KA, Duerr-Stoerzer S, Keppeler H, Schumm M, Handgretinger R, et al. Conference contribution The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study (2018) Tietze JK, Forschner A, Loquai C, Mitzel-Rink H, Zimmer L, Meiss F, Rafei-Shamsabadi D, et al. Journal article Causes for delayed defibrillation: A simulation study Gründe für eine verzögerte Defibrillation: Eine Simulationsstudie (2018) Castan C, Muench A, Mahling M, Haffner L, Griewatz J, Hermann-Werner A, Riessen R, et al. Journal article THE USE OF TTFIELDS FOR NEWLY DIAGNOSED GBM PATIENTS IN GERMANY IN ROUTINE CLINICAL CARE (TIGER: TTFIELDS IN GERMANY IN ROUTINE CLINICAL CARE) (2018) Baehr O, Tabatabai G, Fietkau R, Goldbrunner R, Glas M Conference contribution A face-aging app for smoking cessation in a waiting room setting: Pilot study in an HIV outpatient clinic (2018) Brinker TJ, Brieske CM, Esser S, Klode J, Mons U, Batra A, Ruther T, et al. Journal article Transcriptomic and metabolomic profiles in renal cell carcinoma (RCC) tumors reflect ontogeny of RCC subtypes (2018) Fisel P, Buettner F, Reustle A, Klumpp V, Winter S, Rausch S, Hennenlotter J, et al. Conference contribution Stimulating Weight Stigma in Future Experimental Designs on Physical Activity – Development and Pilot Validation of a Video Instrument (2018) Carl J, Thedinga H, Zipfel S, Thiel A Journal article Konsensusempfehlung des Deutschen Konsortiums Familiärer Brust- und Eierstockkrebs zum Umgang mit Ergebnissen der Multigenanalyse (2018) Waha A, Versmold B, Kast K, Kiechle M, Ditsch N, Meindl A, Niederacher D, et al. Journal article Treatment efficacyand safety of seladelpar, a selective peroxisome proliferator-activated receptor delta agonist, in primary biliary cholangitis patients: 12-and 26-week analysis from an ongoing international, randomized, dose raging phase 2 study (2018) Hirschfield G, Boudes P, Bowlus C, Gitlin N, Michael G, Harrison S, Gordon SC, et al. Conference contribution